BACKGROUND
Platelet reactivity testing may help tailor antithrombotic regimens after percutaneous coronary intervention (PCI). We sought to describe antithrombotic practices and assess 30-day outcomes in patients treated at an academic cardiac catheterization laboratory who underwent platelet reactivity testing followi...
Daniel J. Snyder, Mahesh V. Madhavan, Seokyu Shin et al.· Cardiovascular Revasculariza...· 0 citations
It is demonstrated that adapting bacteria to the unique characteristics of the tumor metabolic microenvironment can drive the development of safer and more effective chassis for next‑generation bacterial cancer therapies.
Noah Chen, Mathieu Rouanne, Zao-Feng Yang et al.· Nature Cancer· 0 citations
Across many solid tumor types, cancer-associated fibroblasts (CAFs) are abundant and heterogeneous, with distinct subpopulations exerting immunomodulatory functions. Here we identify a novel population of immunomodulatory CAFs (imCAFs) in primary lung adenocarcinoma and pulmonary metastases, characterized by cell adhes...
Olivia R. Ringham, Monica Rivera, Lucas F. Loffredo et al.· Nature Immunology· 1 citation
The approach integrates enzyme/prodrug therapy and immunotherapy into a single bacterial delivery system, overcoming key limitations of conventional therapies by providing a rationally designed framework for spatially controlled chemoimmunotherapy.